Quantcast
Last updated on April 21, 2014 at 5:21 EDT

Latest pharmaceutical industry Stories

2014-04-04 23:29:56

MannKind's AFREZZA takes a big step towards FDA approval. Princeton, NJ (PRWEB) April 03, 2014 PharmApprove, the leading strategic, regulatory, and scientific communications consultancy to the pharmaceutical and biotech industries, congratulates client MannKind Corporation on its successful U.S. Food and Drug Administration (FDA) Endocrine and Metabolic Advisory Committee meeting this week. The committee voted 13 to 1 on April 1 to recommend that MannKind’s AFREZZA® (insulin...

2014-04-04 20:21:51

CHAPEL HILL, N.C., April 4, 2014 /PRNewswire/ -- In the face of technology advances and regulatory pressures, the pharmaceutical and medical device industries are changing how they approach medical education. It's in this environment of transition that many organizations are struggling to have the right staffing, investment, and delivery platforms to provide valuable education opportunities for healthcare practitioners. Research and consulting firm Best Practices®, LLC has published a...

2014-04-04 20:21:41

CHAPEL HILL, N.C., April 4, 2014 /PRNewswire/ -- Corporate library and information centers, especially in the pharmaceutical sector, are increasingly being challenged to provide value to their organizations while simultaneously balancing budget, resource and service levels. To survive in this difficult environment and to have the greatest impact for their customers, library leaders have to effectively cope with the many forces of change that are shaping their business models, services, and...

2014-04-04 16:23:39

TARRYTOWN, N.Y., April 4, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has elected Robert A. Ingram to its Board of Directors. Regeneron also announced that Dr. Eric Shooter, a co-founder of the Company, is retiring from the Board after nearly 26 years of service to Regeneron. Mr. Ingram was nominated to become a member of Regeneron's Board by Sanofi. Under the terms of an investor agreement between Regeneron and Sanofi, Sanofi...

2014-04-04 12:27:30

ChinaMarketResearchReports.com adds Research Report on "China Pharmaceutical Glass Packaging Industry Report, 2013-2016" to its store. DALLAS, April 4, 2014 /PRNewswire-iReach/ -- Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceutical glass packaging industry develops sluggishly. In 2013, China's pharmaceutical glass bottle market capacity...

2014-04-04 08:25:09

REDWOOD CITY, Calif., April 4, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Richard King, President and CEO, and Timothy E. Morris, CFO, will present a Company update on April 9(th). Presentation details are as follows: 13(th) Annual Needham Healthcare Conference Date: Wednesday,...

2014-04-03 12:30:06

LONDON, April 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Injectable Generic and Biosimilar Drugs - Potential Opportunities for Developers 2013 The market for injectable generics has been through a period of consolidation over the last few years as the leading companies have increased their presence through acquisition. The major players include Hospira, Sandoz (Novartis), Hikma Pharmaceuticals, Fresenius Kabi and Teva Pharmaceutical...

2014-04-03 12:29:55

Great milestones for patient recruitment have been achieved through WCCT Global's Social Media Following COSTA MESA, Calif., April 3, 2014 /PRNewswire-iReach/ -- WCCT Global (WCCTG), a contract research organization headquartered in Southern California announced today that due to their quickly growing Facebook page following of clinical trial volunteers, they now have the ability to directly reach over 240,000 people. The use of social media (SM) for clinical trial patient...

2014-04-03 12:29:36

Undermining Maximum Allowable Cost Lists Could Cost Florida Over $420 Million Annually WASHINGTON, April 3, 2014 /PRNewswire-USNewswire/ -- Legislation that (SB 1014) passed out of the Florida Senate Appropriations Subcommittee on General Government would create new powers for independent drugstores to charge employers, seniors and unions higher prices for generic drugs, the Pharmaceutical Care Management Association (PCMA) said today. The new legislation, along with a similar bill (HB 765),...

2014-04-03 08:31:17

Fuld & Company White Paper Released CAMBRIDGE, Mass., April 3, 2014 /PRNewswire/ -- A Fuld & Company white paper which chronicles the history of Forest Laboratories and its market position that led to its acquisition by Actavis was released today. The white paper http://bit.ly/1lAw5Lo provides details including: -- Forest's actions in recent years that made it acquisition bait -- How one of the most successful US pharmaceutical companies of the last decade finds itself...